Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In adolescents with obesity cardiopulmonary exercise testing (CPET) has become an important clinical examination providing valuable information with regard to the integrative exercise responses, including the pulmonary, cardiovascular and muscular systems.
During CPET, mechanical constraints in ventilation, an elevated risk for hypoxia and chronotropic incompetence (CI) (defined as the inability of the heart to increase its rate with increased activity), or compromised cardiac function (e.g. lowered heart rate (HR) recovery, chronotropic index and stroke volume) are often observed in obese adults. Moreover, several studies regarding exercise capacity and cardiopulmonary responses to maximal endurance exercise testing have been performed in obese adolescents. Despite these previous investigations in obese adolescents it remains controversial whether cardiopulmonary disturbances can be observed consistently during CPET. However, a number of studies have reported a suboptimal response to exercise, in particular a reduced peak heart rate (HRpeak) and peak cycling power output (Wpeak). Adult obesity modifies cardiac behavior, including resting HR and CI, which has a marked effect on exercise capacity. Therefore, chronotropic variables are the most important factors that affect exercise performance. It has been shown that both peak and resting HR account for over forty percent of variability of exercise capacity. Interestingly, resting HR and HR response to exercise, including a blunted HR increase, low chronotropic index and HR recovery, are important predictors of all-cause mortality and cardiovascular death, at least in adults. These changes in HR during and recovery from CPET are mediated by the balance between sympathetic and vagal activity of the autonomic nervous system. Adverse cardiovascular outcomes associated with the metabolic syndrome may be mediated by autonomic dysfunction, whereby obesity is characterized by sympathetic predominance and a decrease in vagal activity in the basal state, where reduced sympathetic responsiveness has been observed during exercise. Therefore, these multiple exercise risk markers could provide valuable clinical information regarding cardiometabolic health. Nonetheless HR behavior during CPET has not been described in obese adolescents. The goal of this study is to examine the HR behavior of obese adolescents during CPET to clarify whether this population suffer from CI.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Obese adolescents with CI | Obese adolescents with chronotropic incompetence |
| |
| Control group | Obese adolescents without chronotropic incompetence |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| The prevalence of chronotropic incompetence during maximal cardiopulmonary exercise testing | Diagnostic Test | The prevalence of chronotropic incompetence during maximal cardiopulmonary exercise testing |
| Measure | Description | Time Frame |
|---|---|---|
| Heart rate (HR) during exercise testing | Assessed using a 12-lead ECG device | day 1 |
| Peak oxygen uptake (VO2) during exercise testing | Cardiopulmonary exercise test on an electronically braked cycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VO2 is collected breath-by-breath and averaged every ten seconds. | day 1 |
| Peak workload during exercise testing | Cardiopulmonary exercise test on an electronically braked cycle ergometer is performed and the incremental workload is measured | day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Body height | Body height is measured to the nearest 0.1cm using a wall-mounted Harpenden stadiometer, with participants barefoot | day 1 |
| Body weight | Body weight (in underwear) is determined using a digital-balanced weighting scale to the nearest 0.1kg |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Obese adolescents
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dominique Hansen, Prof. | Contact | +32(0)11 292126 | dominique.hansen@uhasselt.be |
| Name | Affiliation | Role |
|---|---|---|
| Dominique Hansen, PhD | Hasselt University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Virga Jesse hospital - Heart centre Hasselt | Recruiting | Hasselt | Limburg | 3500 | Belgium |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D063766 | Pediatric Obesity |
| D006331 | Heart Diseases |
| ID | Term |
|---|---|
| D009765 | Obesity |
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
| day 1 |
| Waist circumference | Waist circumference will be measured to the nearest 0.1cm using a flexible metric measuring tape with participants barefoot (in underwear) in standing position. Waist circumference is measured at the midpoint between the lower rib margin and the top of the iliac crest. | day 1 |
| Hip circumference | Hip circumference will be measured to the nearest 0.1cm using a flexible metric measuring tape with participants barefoot (in underwear) in standing position. Hip circumference is measured at the widest circumference of the hip at the level of the greater trochanter. | day1 |
| Physical activity questionnaire for adolescents (PAQ-A) | physical activity determined using the validated Dutch physical activity questionnaire for adolescents | day 1 |
| Tanner stage | Puberty stage (ranging from 1 to 5) will be assessed in all participants by the pediatric endocrinologist using Tanner staging criteria. | day 1 |
| Plasma glucose | Blood analyses | day 1 |
| Total cholesterol | Blood analyses | day 1 |
| High-density lipoprotein cholesterol | Blood analyses | day 1 |
| Low-density lipoprotein cholesterol | Blood analyses | day 1 |
| Triglyceride concentration | Blood analyses | day 1 |
| C-reactive protein | Blood analyses | day 1 |
| Serum leptin concentration | Blood analyses | day 1 |
| Insulin | Blood analyses | day 1 |
| Homeostatic model assessment for insulin resistance (HOMA-IR) | Homeostatic model assessment for insulin resistance calculated from insulin and glucose concentration | day 1 |
| Carbon dioxide output (VCO2) during exercise testing | Cardiopulmonary exercise test on an electronically braked cycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VCO2 is collected breath-by-breath and averaged every ten seconds. | day 1 |
| Minute ventilation(VE) during exercise testing | Cardiopulmonary exercise test on an electronically braked cycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis VE is collected breath-by-breath and averaged every ten seconds. | day 1 |
| Tidal volume (Vt) during exercise testing | Cardiopulmonary exercise test on an electronically braked cycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis Vt is collected breath-by-breath and averaged every ten seconds. | day 1 |
| Breathing frequency (BF) during exercise testing | Cardiopulmonary exercise test on an electronically braked cycle ergometer is performed. With the aid of continuous pulmonary gas exchange analysis BF is collected breath-by-breath and averaged every ten seconds. | day 1 |
| D009750 |
| Nutritional and Metabolic Diseases |
| D001835 | Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D002318 | Cardiovascular Diseases |